Ark Invest prioritizes companies with AI
Ark Invest buys $13.9 million in Tempus AI to deepen healthcare AI bet
Cathie Wood’s Ark Invest has deepened its commitment to the health-tech space with a fresh purchase of 251,080 shares in Tempus AI, valued at approximately $13.9 million.
The acquisition, made on May 28, 2025, came shortly after a brief pullback in Tempus’s stock price, aligning with Ark’s contrarian approach of buying during market dips, reports Crypto News.
Tempus, a recently listed firm, leverages artificial intelligence to personalize cancer care and treatment for complex diseases. The move reflects Wood’s conviction that AI will play a transformative role across sectors, particularly in healthcare. The purchase signals confidence in Tempus’s ability to scale its platform and data capabilities for clinical impact.
AI as a healthcare catalyst
Ark’s latest investment builds on its long-standing belief that artificial intelligence is reshaping the future of medicine. Tempus’s focus on real-world clinical data and predictive modeling echoes Wood’s vision for technology’s role in precision care.
Since mid-2024, Ark has been steadily increasing exposure to firms that fuse AI with biology and diagnostics. With this latest move, Ark’s total holdings in Tempus now stand at $284.8 million, making it the sixth-largest position across the firm’s actively managed ETFs. The company now accounts for roughly 5% of Ark’s total ETF portfolio, underscoring its strategic importance.
Reallocating capital toward innovation
The Tempus purchase coincides with a broader reshuffle within Ark’s portfolio. The firm has trimmed its positions in Tesla, Roblox, and CoreWeave to make room for emerging tech leaders. In parallel, Ark has continued building stakes in AI and biotech powerhouses like Nvidia, AMD, and Intellia Therapeutics.
Crypto remains on the radar too, with holdings in Coinbase and its own Bitcoin ETF, ARKB. The Tempus deal is yet another signal that Ark is pivoting toward companies driving innovation at the intersection of data, biology, and machine learning—an area Cathie Wood sees as central to the next wave of disruption.
Recently we wrote that Cathie Wood’s Ark Invest is expanding its holdings in Coinbase, signaling continued confidence in the long-term potential of the crypto market despite ongoing market turbulence.
